This month, Cyprus assumed the rotating Presidency of the Council of the European Union, under the overarching motto ‘An Autonomous Union. Open to the World’. The motto reflects a forward-looking approach that combines internal strength and independence with openness, cooperation and global engagement.
The Cyprus Presidency is guided by five broad priorities:
Autonomy through security, defence readiness and preparedness;
Autonomy through competitiveness;
Open to the world and autonomous;
An autonomous Union of values that leaves no one behind; and
A long-term budget for an autonomous Union…
Čtěte více
The European Commission has published the Horizon Europe Work Programmes for 2026–2027, confirming EUR 14 billion in EU investment to support research and innovation across Europe over the next two years. In line with the EUDA mandate (1), we have reviewed the programmes and identified a set of upcoming Horizon Europe calls of relevance to drug-related research and innovation. These calls span multiple parts of the programme, including:
Cluster 1: Health — addressing prevention, mental health, non-communicable diseases and health systems.
Cluster 3: Civil Security for Society — including…
Čtěte více
This week, the European Union Drugs Agency (EUDA) welcomes its new Executive Director Dr Lorraine Nolan (Ireland), as she begins a five-year term leading the agency.
Dr Nolan was elected to the position by the EUDA Management Board in June 2025, following a competitive public recruitment process launched in September 2024.
Dr Nolan brings over 25 years of senior leadership experience across science, public service and regulatory affairs, including 10 years as Chief Executive of Ireland’s Health Products Regulatory Authority (HPRA). Her career spans national, European and international roles…
Čtěte více
